Technetium-99m labelled macroaggregated albumin arterial catheter perfusion scintigraphy: Prediction of gastrointestinal toxicity in hepatic arterial chemotherapy

European Journal of Nuclear Medicine

Volumn 27, Issue 6, 2000, Pages 668-675

  Pelosi, Ettore ^a   Masaneo, Isabella ^a   Clara, Renzo ^a   Valetto, Maria Rosa ^a   Bellò, Marilena ^a   Zanon, Claudio ^a   Chiappino, Isabella ^a   Grosso, Maurizio ^b   Mussa, Antonio ^a   Bisi, Gianni ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

Arterial perfusion scintigraphy; Gastrointestinal toxicity; Intrahepatic arteriovenous shunt Regional chemotherapy; Secondary liver neoplasms

Indexed keywords

DEXAMETHASONE; FLOXURIDINE; FOLINIC ACID; MACROSALB TC 99M;

ADULT; AGED; ARTERIOVENOUS SHUNT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; DRUG INFUSION; FEMALE; FIRST PASS EFFECT; GASTROINTESTINAL TOXICITY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SCINTIGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CATHETERIZATION, PERIPHERAL; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM; FEMALE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0034082079     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050561     Document Type: Article

References (39)

1. 1. Silverberg E, Boring CE, Sequires TS. Cancer statistics 1991. CA Cancer J Clin 1991 41: 19-36.
2. 2. Wagner JS, Adson MA, VanHeerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastasis from colorectal cancer. Ann Surg 1989; 1: 201-209.
3. 3. Sugihara K, Hojo K, Moriya Y, Yamasaky S, Kosuge T, Takayama T. Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 1993; 80: 1032-1035.
4. 4. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997; 132: 505-510.
5. 5. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
6. 6. Kemeny N, Cohen A, Huang Y, et al. Randomized study of hepatic arterial infusion (HAI) and systemic chemotherapy (SYS) versus SYS alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer [abstract]. Proceedings of the 35th Annual Meeting of the American Society of Clinical Oncology (ASCO), Atlanta, Ga., US, May 15-18 1999, 1011.
7. 7. Kemeny MM, Adak S, Lipsitz S, Gray B, McDonald J, Benson AB. Results of the intergroup [Eastern Cooperative Oncology Group (ECOG) and South West Oncology Group (SWOG)] prospective randomized study of surgery alone versus continuous hepatic artery infusion of FUDR and continuous systemic infusion of 5FU after hepatic resection of liver metastases [abstract]. Proceedings of the 35th Annual Meeting of the American Society of Clinical Oncology (ASCO), Atlanta, Ga., US, May 15-18 1999, 1012.
8. 8. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107: 459-465.
9. 9. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous vs hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver. The Northern California Oncology Trial. J Clin Oncol 1989; 7: 1646-1654.
10. 10. Martin JK Jr, O'Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer: a randomized trial. Arch Surg 1990; 125: 1022-1027.
11. 11. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomixed trial. J Clin Oncol 1992; 10: 1112-1118.
12. 12. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996; 88: 252-258.
13. 13. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-985.
14. 14. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974; 75: 589-596.
15. 15. Lin G, Lunderquist A, Hägerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 1984; 96: 517-526.
16. 16. Ensminger WD, Rosowsky A, Raso V, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res 1978; 38: 3784-3792.
17. 17. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984; 2: 498-504.
18. 18. Chen H-SG, Gross JF. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1990; 64: 31-40.
19. 19. Arai Y. The study of catheter placement into the hepatic artery via the left subclavian artery for hepatic infusion therapy. J Nagoya City Univ Med Assoc 1988; 39: 453-464.
20. 20. Zanon C, Grosso M. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumours [letter]. Eur J Cancer 1996; 32: 1824-1825.
21. 21. Matsuma T, Yamagishi H, Jin MB, Kobayashi Y, Sonoyama T, Oka T. Laparotomy versus interventional radiological procedures for implantation of arterial infusion devices. Surg Today 1997; 27: 398-402.
22. 22. Castaing D, Azoulay D, Fecteau AH, Bismuth H. Implantable hepatic arterial infusion device: placement without laparotomy via an intercostal artery. Am Coll Surg 1998; 187: 565-568.
23. 23. Kemeny N, Daly J, Oderman P, et al. Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 1984; 2: 595-600.
24. 24. Allen-Mersh TG, Earlem S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 334: 1255-1260.
25. 25. Vauthei N, Marsh De W, Cendan JC, Chu NM, Copeland EM. Arterial therapy of hepatic colorectal metastases. Br J Surg 1996; 83: 447-455.
26. 26. Pelosi E, Bar F, Battista S, et al. Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a scintigraphic and pharmacokinetic approach. Cancer Chemother Pharmacol 1999; 44: 505-510.
27. 27. Kaplan WD, Ensminger WD, Come SE, et al. Radionuclide angiography to predict patients response to hepatic artery chemotherapy. Cancer Treat Rep 1980; 64: 1217-1222.
28. 28. Ensminger WD, Niederhuber JE, Shaker D, Thrall JH, Wheeler R. Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 1981; 65: 393-400.
29. 29. Yang PJ, Thrall JH, Ensminger WD, et al. Perfusion scintigraphy (Tc-99m-MAA) during surgery for placement of chemotherapy catheter in hepatic artery: concise communication. J Nucl Med 1982; 23: 1066-1069.
30. 30. Kaplan WD, Come SE, Takvorian RW, Laffin SM, Gelman RS, Weiss GR, Garnick MB. Pulmonary uptake of technetium 99m macroaggregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion. J Clin Oncol 1984; 2: 1266-1269.
31. 31. Bledin AG, Kim EE, Harle TS, Haynie TP, Chuang VP. Technetium-99m-labeled macroaggregated albumin arteriography for detection of abnormally positioned arterial catheters during infusion chemotherapy. Cancer 1984; 53: 858-862.
32. 32. Royal HD, Brown ML, Drum DE, Nagle CE, Sylvester JM, Ziessman HA. Procedure guideline of hepatic and splenic imaging. J Nucl Med 1998; 39: 1114-1116.
33. 33. Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer 1994; 73: 1134-1142.
34. 34. Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone vs fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992; 69: 327-334.
35. 35. WHO Handbook for reporting results of cancer treatment. WHO Offset Publication nr. 48. Geneva, 1979.
36. 36. Kemeny MM, Alava G, Olivier JM. The effect on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR. HPB Surg 1994; 7: 219-224.
37. 37. Kemeny N, Conti JA, Cohen A, et al. Phase 2 study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994; 12: 2288-2295.
38. 38. Goldberg JA, Bradnam MS, Haughton DM, et al. Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. Nucl Med Commun 1987; 8: 1033-1046.
39. 39. Goldberg JA, Thomson JAK, McCurrach G, et al. Arteriovenous shunting in patients with colorectal liver metastases. Br J Cancer 1991; 63: 466-468.